AstraZeneca PLC

Broker Recommendation (11 Brokers)GlossaryGo to Portfolio

STRONG SELLSTRONG BUY
HOLD
Broker Consensus
 20092010
 Pre-tax (£)EPS (p)DPS (p)Pre-tax (£)EPS (p)DPS (p)
Consensus7,316.58373.21138.827,028.88353.35146.43
1 Month Change116.949.79-2.11-142.30-2.25-1.24
3 Month Change468.0816.41-5.37140.2912.632.32
Growth
 2008 (A)2009 (E)2010 (E)
Norm. EPS%63.995.23-5.32
DPS%8.1545.365.48
Investment Ratios
 2008 (A)2009 (E)2010 (E)
EBITDA£m8,304.078,217.007,547.13
EBIT£m7,041.568,037.387,092.93
Dividend Yield%3.53%5.13%5.41%
Dividend Coverx3.712.692.41
PERx7.637.257.66
PEGf0.121.39-1.44
Net Asset Value PSp-297.77866.001,086.29

Brokers

The consensus above is compiled from contributions by the following brokers:

WestLB, SG Securities, Panmure Gordon, Exane BNP Paribas, Shore Capital, Charles Stanley, Evolution Securities Ltd, Astaire Securities, ABN AMRO, Nomura Research Institute, NCB Stockbrokers Ltd